Decibel Therapeutics Inc
DBTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$123.37M
Close$
Share Statistics
| Market cap | $123.37 Million |
|---|---|
| Enterprise Value | $96.42 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.52 |
| Beta | -0.4 |
| Outstanding Shares | 25,017,851 |
Return
| Return on Equity | -118.91% |
|---|---|
| Return on Assets | -67.16% |
| Return on Invested Capital | -97.33% |
Valuation & Multiples
| P/E Ratio | -1.95 |
|---|---|
| PEG | -30.17 |
| Price to Sales | - |
| Price to Book Ratio | 2.46 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.46 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.24 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Decibel Therapeutics Inc
40 employeesDecibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, one of the largest areas of unmet need in medicine. Decibel has ...